Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Fentanyl Market Growth in 2025?

The market size for fentanyl has seen significant growth in the past few years. It is projected to increase from $16.22 billion in 2024 to $17.31 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%. The surge during the historical period can be credited to the necessity for pain management, medical procedures and surgeries, management of pain related to cancer, growth in the opioid analgesic market, and an aging population.

What Is the Forecast for the Fentanyl Market Size Through 2029?

The marketplace for fentanyl is predicted to experience robust expansion in the upcoming years, with a projection to reach $22.31 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth in the prediction period include a surge in instances of chronic pain, the proliferation of cancer treatments, an increase in surgical procedures, public health measures, and regulatory endorsement for new therapeutic uses. Key trends anticipated during the forecast period consist of advancements in the formulation of drugs, innovations in detection technology, strategies for public health and harm reduction, a surge in applications in the pharmaceutical industry, and international cooperation and exchange of information.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

What are the Key Market Players in Fentanyl Market and How They’re Evolving?

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

What Are the Primary Growth Drivers in the Fentanyl Market?

The fentanyl market is seeing growth as the incidence of chronic illnesses rises. Chronic illnesses are those that persist for extended periods, often affecting a person throughout their entire life, usually lasting at least three months. One of the main uses of fentanyl in the treatment of chronic illnesses is to address intractable, severe pain that doesn’t respond to other remedies or procedures. For example, the Heart Disease Facts from the Centers for Disease Control and Prevention (CDC), a public health organization in the US, reported in October 2024 that coronary heart disease (CHD) caused 371,506 deaths in 2022. These deaths contributed to a total of 702,880 heart disease deaths, approximately 1 in every 5 deaths. Thus, the climb in chronic disease rates contributes to the expansion of the fentanyl market. The surge in demand for pain control is also predicted to stimulate the progress of the fentanyl market. Pain management, a medical field that concentrates on reducing pain to enhance the quality of life for patients, employs fentanyl as a powerful opioid that offers significant pain alleviation. It’s particularly effective for people with chronic or severe pain because it lowers pain levels, improves physical function, and treats the root causes of pain. A report from the Pain Relief Foundation, a charity based in the UK, in May 2022 showed that arthritis and musculoskeletal issues affect over 17 million UK citizens and result in 30 million lost workdays every year. Additionally, chronic pain afflicts up to 62% of individuals over 75, showing an increasing burden of pain as the population ages. This escalating need for effective pain management fuels the growth of the fentanyl market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

What Are the Leading Segments in the Global Fentanyl Industry?

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

What Are the Key Market Trends in the Fentanyl Industry?

In an effort to increase their customer base, sales, and revenue, prominent businesses in the fentanyl market are focusing on the development of innovative products such as Opvee and achieving the necessary regulatory approvals. Opvee (nalmefene), a potent blocker of opioid receptors, is used to treat overdoses triggered by natural or synthetic opioids such as fentanyl. Indivior PLC, a pharmaceutical firm based in the U.S., is one such company that received U.S. Food and Drug Administration approval for Opvee nasal spray in May 2023. This product works by counteracting the effects of opioids on the brain, aiding patients who have recently overdosed to return their respiration and blood pressure to normal levels. Opvee, provided as a nasal spray, is easy to use in emergency situations and plays a crucial role in the array of medications used to address opioid overdoses, thereby saving lives.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

What Is the Regional Outlook for the Fentanyl Market?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13237

This Report Delivers Insight On:

1. How big is the fentanyl market, and how is it changing globally?

2. Who are the major companies in the fentanyl market, and how are they performing?

3. What are the key opportunities and risks in the fentanyl market right now?

4. Which products or customer segments are growing the most in the fentanyl market?

5. What factors are helping or slowing down the growth of the fentanyl market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model